The Role of DLOTCA-G in the Cognitive Function Evaluation of Parkinson's Patients

Kutahya Health Sciences University

Status

Completed

Conditions

Parkinson Disease

Treatments

Other: assesment of cognitive parameters with DLOTCA-G

Study type

Observational

Funder types

Other

Identifiers

NCT06131619

2021/15-03

Details and patient eligibility

About

The purpose of this study is to evaluate the usefulness of Dynamic Loewenstein's Occupational Therapy and Cognitive Assessment Scale for Geriatrics (DLOTCA-G) in parkinson patients.

Full description

The purpose of this study to evaluate the usefulness of Dynamic Loewenstein's Occupational Therapy and Cognitive Assessment Scale for Geriatrics (DLOTCA-G) in the early detection of cognitive impairment in parkinson patients aged 65 and over, with and without dementia.The investigators also aimed to compare the Mini Mental State Assessment Test with DLOTCA-G.

Enrollment

90 patients

Sex

All

Ages

65 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusıon Criteria

Parkinson's patients aged 65 years and older with and without cognitive impairment (60 patients) and healthy control patients (30 patients)
Hoehnn Yahr Staging between 1 and 2.5 in patients with Parkinson's diseas
Confirmed by brain MRI from patients without vascular dementia who routinely attend the Parkinson's follow-up outpatient clinic
At least primary school graduates
In patients with Parkinson's dissease patients with cognitive impairment, MMSE below 20 in primary school education level; below 24 in secondary, high school and university education level
In patients with Parkinson's disease without cognitive impairment, MMSE 20 and above in primary school education level; 24 and above in secondary, high school and university education level Exclusıon Criteria
Preexisting cognitive impairment
Psychiatric disorders such as psychotic disorders, mood disorders, alcohol or drug abuse
Severe language dysfunction and/or bilateral limb motor dysfunction and inability to participate in clinical psychology tests, severe visual and/or auditory impairments
Patients with significant cerebral atrophy or neurological vascular lesions
The Geriatric Depression Scale was administered to all participants, and participants with a total score of 13 or more out of 30 points were excluded from the study.